CLIMB BIO, INC. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
CLIMB BIO, INC. (CLYM) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$589.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-06
- CLIMB BIO, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $943.00K.
- CLIMB BIO, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was -$1.53M, a 175.28% decline year-over-year.
- CLIMB BIO, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $220.00K, a 78.52% decline year-over-year.
- CLIMB BIO, INC. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was -$792.00K, a 933.68% decline year-over-year.
- CLIMB BIO, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $372.00K, a 74.26% decline from fiscal 2024.
- CLIMB BIO, INC. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was $1.45M.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $943.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$589.00K 10-Q · filed 2026-08-06 | -$369.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.16M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$1.53M 10-Q · filed 2026-05-07 | -$1.31M derived: sum of 2 quarters · filed 2026-05-07 | -$2.10M derived: sum of 3 quarters · filed 2026-05-07 | -$3.19M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $220.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$572.00K derived: sum of 2 quarters · filed 2026-03-05 | -$1.66M derived: sum of 3 quarters · filed 2026-08-06 | $372.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | -$792.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.88M derived: sum of 2 quarters · filed 2026-08-06 | $152.00K 10-Q · filed 2025-11-06 | $1.18M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$1.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $944.00K 10-Q · filed 2026-08-06 | $1.97M derived: sum of 3 quarters · filed 2026-08-06 | $2.06M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $2.04M 10-Q · filed 2026-05-07 | $3.06M derived: sum of 2 quarters · filed 2026-05-07 | $3.15M derived: sum of 3 quarters · filed 2026-05-07 | |
| 2024-12-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $1.12M derived: sum of 2 quarters · filed 2026-03-05 | $1.45M 10-K · filed 2026-03-05 | |
| 2024-09-30 | $95.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $421.00K 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | $326.00K 10-Q · filed 2025-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |